![](https://www.diabetesnews.com/wp-content/uploads/2012/10/199845-pill_bottle_and_pills_large-150x150.jpg)
Hopes are high: Headlines about “blockbuster” and “game-changer” diet drugs emerge alongside grim reports about the obesity epidemic, which affects about 36% of adults in the United States. The latest medication to join the pack is Saxenda, the name for liraglutide, which the Food and Drug Administration approved in December.